Filing Details

Accession Number:
0000749660-14-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-03 18:21:15
Reporting Period:
2014-12-01
Filing Date:
2014-12-03
Accepted Time:
2014-12-03 18:21:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
749660 Icad Inc ICAD Surgical & Medical Instruments & Apparatus (3841) 020377419
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362512 M Stacey Stevens C/O Icad, Inc.
98 Spit Brook Road, Suite 100
Nashua NH 03062
Sr Vp Of Marketing & Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-01 299 $5.75 63,030 No 4 M Direct
Common Stock Acquisiton 2014-12-02 503 $5.75 63,533 No 4 M Direct
Common Stock Acquisiton 2014-12-03 1,700 $5.75 65,233 No 4 M Direct
Common Stock Disposition 2014-12-01 299 $10.00 64,934 No 4 S Direct
Common Stock Disposition 2014-12-02 503 $10.01 64,431 No 4 S Direct
Common Stock Disposition 2014-12-03 1,700 $10.00 62,731 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2014-12-01 299 $0.00 209 $5.75
Common Stock Employee Stock Option (right to buy) Disposition 2014-12-02 503 $0.00 503 $5.75
Common Stock Employee Stock Option (right to buy) Disposition 2014-12-03 1,700 $0.00 1,700 $5.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,701 2011-03-29 2021-03-29 No 4 M Direct
19,198 2011-03-29 2021-03-29 No 4 M Direct
17,498 2011-03-29 2021-03-29 No 4 M Direct
Footnotes
  1. This sale is made pursuant to a trading plan previously entered into by the reporting person and complies with the requirements of Rule 10b5-1(c)(1)under the Securities Exchange Act of 1934, as amended.
  2. The reporting securites were executed in multiple trades with prices ranging between $10.00 and $10.03. The reporting person hereby undertakes to provide, upon request, to the SEC Staff, the Issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the trasactions were effected.